BRCA1 and BRCA2 gene mutation analysis: Visit to the Breast Cancer Information Core (BIC)

被引:0
|
作者
Shen, DJ [1 ]
Vadgama, JV [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Charles R Drew Univ Med & Sci, Dept Med,Div Lab Res & Dev,Mol Oncol Program, Los Angeles, CA 90059 USA
关键词
BRCA1; BRCA2; mutation; Breast Cancer Information Core (BIC);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a leading cancer in American women. About 7% of breast cancer is due to inheritance of mutated genes BRCA1 and BRCA2. Numerous investigations have revealed a number of mutations in BRCA1 and BRCA2 genes. The inheritance of the mutated BRCA1 or BRCA2 genes accounts for 45% and 35%, respectively, of hereditary breast cancers. A central database named Breast Cancer Information Core (BIC) has been established in the National Human Genome Research Institute (NHGRI) to coordinate the information related with BRCA1 and BRCA2 research. Nearly half of the mutations (49%) in the BRCA1 gene are frameshift mutations and the cancer-causing mutations account for 66% of all entries. However, for the BRCA2 gene frameshift mutations and cancer-causing mutations account for only 35% and 43%, respectively, of all entries. The significance of a large portion of missense sequence variants (24% of BRCA1 mutations and 47% of BRCA2 mutations) needs further evaluation. The incidence of 185delAG and 5382insC in BRCA1 gene and 6174delT in BRCA2 gene is predominantly high and the founder effect of these mutations is discussed.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 50 条
  • [1] Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
    Friedman, LS
    Gayther, SA
    Kurosaki, T
    Gordon, D
    Noble, B
    Casey, G
    Ponder, BAJ
    AntonCulver, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (02) : 313 - 319
  • [2] BRCA1 and BRCA2 mutation analysis in Irish breast cancer families
    McDevitt, T
    Miller, N
    Ormiston, W
    Cody, N
    Daly, PA
    McDermott, E
    Carney, DE
    Green, AJ
    Barton, DE
    AlKindi, S
    O'Malley, K
    Nolan, C
    JOURNAL OF MEDICAL GENETICS, 2000, 37 : S35 - S35
  • [3] Prognosis of BRCA1 and BRCA2 mutation carriers with breast cancer
    Rennert, G
    Bisland-Becktell, S
    Almog, R
    Zhang, S
    Rennert, HS
    Narod, S
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (02) : 221 - 221
  • [4] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K
    Lynch, HT
    Chadirian, P
    Tung, N
    Olivotto, V
    Warner, E
    Olopade, OI
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Foulkes, WD
    Narod, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2328 - 2335
  • [6] BRCA1 and BRCA2 in breast cancer
    Yang, XH
    Lippman, ME
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (01) : 1 - 10
  • [7] BRCA1 and BRCA2 in breast cancer
    Lee, WH
    Boyer, TG
    LANCET, 2001, : S5 - S5
  • [8] BRCA1 and BRCA2 in breast cancer
    Xiaohong Yang
    Marc E. Lippman
    Breast Cancer Research and Treatment, 1999, 54 : 1 - 10
  • [9] Mutation analysis of the BRCA1 and BRCA2 genes in Japanese breast cancer families
    Miki, Y
    Katagiri, T
    Nakamura, Y
    FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 405 - 407
  • [10] Mutation analysis of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
    Steinmann, D
    Bremer, M
    Rades, D
    Stuhrmann, M
    Schmidtke, J
    Karstens, JH
    Dörk, T
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (04): : B11 - B11